Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

A high TP53 mutation burden is a strong predictor of primary refractory mantle cell lymphoma

A. Obr, P. Klener, T. Furst, E. Kriegova, Z. Zemanova, H. Urbankova, A. Jirkuvova, A. Petrackova, D. Malarikova, K. Forsterova, B. Cudova, L. Sedlarikova, A. Berkova, N. Kasalova, T. Papajik, M. Trneny

. 2020 ; 191 (5) : e103-e106. [pub] 20200830

Jazyk angličtina Země Velká Británie

Typ dokumentu dopisy, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc21011774

Grantová podpora
PROGRES Q26/LF1 Ministry of Health of the Czech Republic, and the Ministry of Education, Youth and Sports
PROGRES Q28/LF1 Ministry of Health of the Czech Republic, and the Ministry of Education, Youth and Sports
IGA_LF_2020_002 Ministry of Health of the Czech Republic, and the Ministry of Education, Youth and Sports
IGA_LF_2020_016 Ministry of Health of the Czech Republic, and the Ministry of Education, Youth and Sports
MH CZ - DRO (FNOL, 00098892) Ministry of Health of the Czech Republic, and the Ministry of Education, Youth and Sports
AZV16-32339A Ministry of Health of the Czech Republic, and the Ministry of Education, Youth and Sports
AZV16-31092A Ministry of Health of the Czech Republic, and the Ministry of Education, Youth and Sports
RVO-VFN64165 Ministry of Health of the Czech Republic, and the Ministry of Education, Youth and Sports
NV17-28980A MZ0 CEP - Centrální evidence projektů

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21011774
003      
CZ-PrNML
005      
20250521102140.0
007      
ta
008      
210420s2020 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/bjh.17063 $2 doi
035    __
$a (PubMed)32862455
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Obr, Ales $u Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, Olomouc, Czech Republic
245    12
$a A high TP53 mutation burden is a strong predictor of primary refractory mantle cell lymphoma / $c A. Obr, P. Klener, T. Furst, E. Kriegova, Z. Zemanova, H. Urbankova, A. Jirkuvova, A. Petrackova, D. Malarikova, K. Forsterova, B. Cudova, L. Sedlarikova, A. Berkova, N. Kasalova, T. Papajik, M. Trneny
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a protokoly protinádorové kombinované chemoterapie $x aplikace a dávkování $7 D000971
650    _2
$a cyklofosfamid $x aplikace a dávkování $7 D003520
650    _2
$a přežití bez známek nemoci $7 D018572
650    _2
$a doxorubicin $x aplikace a dávkování $7 D004317
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    12
$a lymfom z plášťových buněk $x farmakoterapie $x genetika $x mortalita $7 D020522
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    12
$a mutace $7 D009154
650    _2
$a prednison $x aplikace a dávkování $7 D011241
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a míra přežití $7 D015996
650    _2
$a nádorový supresorový protein p53 $x genetika $7 D016159
650    _2
$a vinkristin $x aplikace a dávkování $7 D014750
655    _2
$a dopisy $7 D016422
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Klener, Pavel $u First Department of Medicine - Hematology, General University Hospital in Prague and First Faculty of Medicine, Charles University, Prague, Czech Republic ; Institute of Pathological Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Furst, Tomas $u Department of Mathematical Analysis and Application of Mathematics, Faculty of Science, Palacky University, Olomouc, Czech Republic
700    1_
$a Kriegova, Eva $u Department of Immunology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, Olomouc, Czech Republic
700    1_
$a Zemanova, Zuzana $u Center of Oncocytogenomics, Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and 1st Faculty of Medicine, Prague, Czech Republic
700    1_
$a Urbankova, Helena $u Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, Olomouc, Czech Republic
700    1_
$a Jirkuvova, Andrea $u Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, Olomouc, Czech Republic
700    1_
$a Petrackova, Anna $u Department of Immunology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, Olomouc, Czech Republic
700    1_
$a Maláriková, Diana $u First Department of Medicine - Hematology, General University Hospital in Prague and First Faculty of Medicine, Charles University, Prague, Czech Republic ; Institute of Pathological Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic $7 xx0332458
700    1_
$a Forsterova, Kristina $u First Department of Medicine - Hematology, General University Hospital in Prague and First Faculty of Medicine, Charles University, Prague, Czech Republic
700    1_
$a Cudova, Barbora $u Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, Olomouc, Czech Republic
700    1_
$a Sedlarikova, Lenka $u Department of Immunology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, Olomouc, Czech Republic
700    1_
$a Berková, Adéla $u Center of Oncocytogenomics, Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and 1st Faculty of Medicine, Prague, Czech Republic $7 xx0325890
700    1_
$a Kasalova, Nela $u Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, Olomouc, Czech Republic
700    1_
$a Papajik, Tomas $u Department of Hemato-Oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital, Olomouc, Czech Republic
700    1_
$a Trneny, Marek $u First Department of Medicine - Hematology, General University Hospital in Prague and First Faculty of Medicine, Charles University, Prague, Czech Republic
773    0_
$w MED00009374 $t British journal of haematology $x 1365-2141 $g Roč. 191, č. 5 (2020), s. e103-e106
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32862455 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210420 $b ABA008
991    __
$a 20250521102138 $b ABA008
999    __
$a ok $b bmc $g 1650218 $s 1132153
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 191 $c 5 $d e103-e106 $e 20200830 $i 1365-2141 $m British journal of haematology $n Br J Haematol $x MED00009374
GRA    __
$a PROGRES Q26/LF1 $p Ministry of Health of the Czech Republic, and the Ministry of Education, Youth and Sports
GRA    __
$a PROGRES Q28/LF1 $p Ministry of Health of the Czech Republic, and the Ministry of Education, Youth and Sports
GRA    __
$a IGA_LF_2020_002 $p Ministry of Health of the Czech Republic, and the Ministry of Education, Youth and Sports
GRA    __
$a IGA_LF_2020_016 $p Ministry of Health of the Czech Republic, and the Ministry of Education, Youth and Sports
GRA    __
$a MH CZ - DRO (FNOL, 00098892) $p Ministry of Health of the Czech Republic, and the Ministry of Education, Youth and Sports
GRA    __
$a AZV16-32339A $p Ministry of Health of the Czech Republic, and the Ministry of Education, Youth and Sports
GRA    __
$a AZV16-31092A $p Ministry of Health of the Czech Republic, and the Ministry of Education, Youth and Sports
GRA    __
$a RVO-VFN64165 $p Ministry of Health of the Czech Republic, and the Ministry of Education, Youth and Sports
GRA    __
$a NV17-28980A $p MZ0
LZP    __
$a Pubmed-20210420

Najít záznam

Citační ukazatele

Možnosti archivace